IN2013MU03491A - - Google Patents
Download PDFInfo
- Publication number
- IN2013MU03491A IN2013MU03491A IN3491MU2013A IN2013MU03491A IN 2013MU03491 A IN2013MU03491 A IN 2013MU03491A IN 3491MU2013 A IN3491MU2013 A IN 3491MU2013A IN 2013MU03491 A IN2013MU03491 A IN 2013MU03491A
- Authority
- IN
- India
- Prior art keywords
- treosulfan
- relates
- present
- improved
- methylsulfonyloxybutyl
- Prior art date
Links
- YCPOZVAOBBQLRI-WDSKDSINSA-N Treosulfan Chemical compound CS(=O)(=O)OC[C@H](O)[C@@H](O)COS(C)(=O)=O YCPOZVAOBBQLRI-WDSKDSINSA-N 0.000 abstract 2
- 238000009472 formulation Methods 0.000 abstract 2
- 239000000203 mixture Substances 0.000 abstract 2
- 229960003181 treosulfan Drugs 0.000 abstract 2
- AFVFQIVMOAPDHO-UHFFFAOYSA-N Methanesulfonic acid Chemical compound CS(O)(=O)=O AFVFQIVMOAPDHO-UHFFFAOYSA-N 0.000 abstract 1
- 238000007911 parenteral administration Methods 0.000 abstract 1
- 239000007787 solid Substances 0.000 abstract 1
- 239000008247 solid mixture Substances 0.000 abstract 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/255—Esters, e.g. nitroglycerine, selenocyanates of sulfoxy acids or sulfur analogues thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Emergency Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Dermatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IN3491MU2013 IN2013MU03491A (pl) | 2013-11-04 | 2014-10-31 | |
| PCT/IN2014/000692 WO2015107534A1 (en) | 2013-11-04 | 2014-10-31 | Lyophilized formulation of treosulfan |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IN3491MU2013 IN2013MU03491A (pl) | 2013-11-04 | 2014-10-31 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IN2013MU03491A true IN2013MU03491A (pl) | 2015-07-31 |
Family
ID=53039936
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IN3491MU2013 IN2013MU03491A (pl) | 2013-11-04 | 2014-10-31 |
Country Status (2)
| Country | Link |
|---|---|
| IN (1) | IN2013MU03491A (pl) |
| WO (1) | WO2015107534A1 (pl) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP7431815B2 (ja) * | 2018-09-26 | 2024-02-15 | メダック ゲゼルシャフト フィア クリニッシェ スペツィアルプレパラーテ ミット ベシュレンクタ ハフトゥンク | トレオスルファンの結晶形 |
| PT4257122T (pt) * | 2018-09-26 | 2026-06-08 | Medac Ges Fr Klinische Spezialprparate Mbh | Liofilizado de treossulfano |
| EP3856252A1 (en) | 2018-09-26 | 2021-08-04 | medac Gesellschaft für klinische Spezialpräparate mbH | Solution comprising treosulfan |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3155702A (en) | 1960-02-22 | 1964-11-03 | Lphivens Kemiske Fabrik Ved A | Stereoisomers and the racemate of butane-1, 2, 3, 4-tetrol-1, 4-di |
| AU2003218110A1 (en) * | 2002-03-12 | 2003-09-29 | Bristol-Myers Squibb Company | C3-cyano epothilone derivatives |
| WO2008135232A1 (en) * | 2007-05-02 | 2008-11-13 | Riccardo Cortese | Use and compositions of purine derivatives for the treatment of proliferative disorders |
| DE102009022046A1 (de) * | 2009-05-16 | 2010-11-18 | Evoria Gmbh | Entfärbte Extrakte der Pflanze Pandanus conoideus |
-
2014
- 2014-10-31 IN IN3491MU2013 patent/IN2013MU03491A/en unknown
- 2014-10-31 WO PCT/IN2014/000692 patent/WO2015107534A1/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| WO2015107534A1 (en) | 2015-07-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PH12020550552A1 (en) | Inhibitors of hepatitis c virus | |
| EA201591748A1 (ru) | Модуляторы p2x7 | |
| NZ729443A (en) | Heterocyclic modulators of lipid synthesis | |
| PH12015501996B1 (en) | Heterocyclic compounds and uses thereof | |
| NZ711982A (en) | Cytotoxic and anti-mitotic compounds, and methods of using the same | |
| EA201400833A1 (ru) | Новые индолизиновые соединения, способ их получения и фармацевтические композиции, содержащие их | |
| EA201591728A1 (ru) | Гетероциклические соединения и способы их применения | |
| MY186547A (en) | 4?-fluoro-2?-methyl substituted nucleoside derivatives | |
| PH12017501539A1 (en) | Disacetoxytubulysin h and analogs thereof | |
| EA201600124A1 (ru) | Новые индолизиновые соединения, способ их получения и фармацевтические композиции, содержащие их | |
| ZA201600415B (en) | Novel derivatives of indole and pyrrole, method for the production thereof and pharmaceutical compositions containing same | |
| MY168212A (en) | A new therapeutical composition containing apomorphine as active ingredient | |
| EA201600122A1 (ru) | Новые изоиндолиновые или изохинолиновые соединения, способ их получения и фармацевтические композиции, содержащие их | |
| GEP201706760B (en) | Novel abexinostate salt, associated crystalline form, preparation method thereof and the pharmaceutical compositions containing same | |
| EA201500821A1 (ru) | Производные 2-замещенных-6-биарилметиламино-9-циклопентил-9н-пуринов, их использование в качестве лекарственных средств и фармацевтических составов | |
| EP3003360A4 (en) | High potency pancreatin pharmaceutical compositions | |
| EA201600394A1 (ru) | Трициклические соединения пиперидина | |
| WO2012061012A3 (en) | 4-amino-2h-pyran-2-one analogs as anticancer agents | |
| PL3004058T3 (pl) | Związki-inhibitory acetylcholinesterazy i agoniści receptorów serotoninergicznych 5ht4, o działaniu propamięciowym, ich sposoby wytwarzania i zawierające je kompozycje farmaceutyczne | |
| MX367773B (es) | Forma salina sólida de la alfa-6-mpeg6-o-hidroxicodona como agonistas opioides y sus usos. | |
| IN2013CH04314A (pl) | ||
| ME01524B (me) | Derivati dihidrobenzoksatiazepina, postupak njihove pripreme i farmaceutska jedinjenja koja ih sadrže te njihova upotreba kao modulatora ampa receptora | |
| EA201590886A1 (ru) | Замещенные производные индола | |
| UA114396C2 (uk) | Фармацевтична композиція з антиішемічною та антигіпертензивною дією | |
| IN2013MU03656A (pl) |